Raymond U. Osarogiagbon, MBBS, Meredith A. Ray, MPH, PhD, Nicholas R

Slides:

Advertisements

Similar presentations

Number of Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer: A Gaussian Curve, Not a Prognostic Factor Marc Riquet, MD, PhD, Antoine Legras, MD,

Advertisements

Elizabeth A. David, MD, David T

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

True Negative Predictive Value of Endobronchial Ultrasound in Lung Cancer: Are We Being Conservative Enough? Bryan A. Whitson, MD, PhD, Shawn S. Groth,

Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.

Chun Chieh Lin, PhD, MBA, Matthew P

Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,

Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Oncologic Outcomes After Surgical Resection of Subcentimeter Non-Small Cell Lung Cancer Matthew J. Schuchert, MD, Arman Kilic, BS, Arjun Pennathur, MD,

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Number of Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer: A Gaussian Curve, Not a Prognostic Factor Marc Riquet, MD, PhD, Antoine Legras, MD,

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Lymph Node Evaluation by Open or Video-Assisted Approaches in 11,500 Anatomic Lung Cancer Resections Daniel J. Boffa, MD, Andrzej S. Kosinski, PhD, Subroto.

Esophagectomy Outcomes in the Endoscopic Mucosal Resection Era

Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer Paul J. Speicher, MD, Zachary W. Fitch,

P Evolution of Survival in a Regional Population-Based US Lung Cancer Resection Cohort Raymond Osarogiagbon, Nicholas Faris, Matthew Smeltzer,

P The Effect of Two Interventions on Attainment of Surgical Quality Measures in Resected Non-Small Cell Lung Cancer (NSCLC) Nicholas Faris, Meredith.

Castigliano M. Bhamidipati, DO, MS, George J

Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,

Neither Maximum Tumor Size nor Solid Component Size Is Prognostic in Part-Solid Lung Cancer: Impact of Tumor Size Should Be Applied Exclusively to Solid.

Loretta Erhunmwunsee, MD, Brian C

Survival After Resection for Metastatic Testicular Nonseminomatous Germ Cell Cancer to the Lung or Mediastinum Kenneth A. Kesler, MD, Laura E. Kruter,

Brendon M. Stiles, MD, Farooq Mirza, MD, Jeffrey L. Port, MD, Paul C

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Andrea S. Wolf, MD, MPH, Scott J

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Age-Related Outcomes of the Ross Procedure Over 20 Years

P The Impact of IASLC 8th Edition Updates for T-Classification for Lung Cancer in a US Population-Based Surgical Resection Cohort Matthew Smeltzer,

P Impact of a Novel Lung Gross Dissection Method on Intrapulmonary Lymph Node Yield G. Spencer, Matthew Smeltzer, Nicholas Faris, Carrie Fehnel,

Ara Chrissian, MD, David Misselhorn, RRT, Alexander Chen, MD

Origins of the Cardiothoracic Surgery Network (CTSNet)

Andrea S. Wolf, MD, William G. Richards, PhD, Michael T

Prevalence, Prognostic Implications, and Survival Modulators of Incompletely Resected Non–Small Cell Lung Cancer in the U.S. National Cancer Data Base

Who Do You Say You Are? The Annals of Thoracic Surgery

Mediastinal Lymph Node Examination and Survival in Resected Early-Stage Non– Small-Cell Lung Cancer in the Surveillance, Epidemiology, and End Results.

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival Pamela Samson, MD, MPHS, Traves.

Utility of Routine PET Imaging to Predict Response and Survival After Induction Therapy for Non-Small Cell Lung Cancer Stephen A. Barnett, MBBS, Robert.

Use of Amiodarone After Major Lung Resection

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Prognostic Significance of Surgical-Pathologic N1 Lymph Node Involvement in Non- Small Cell Lung Cancer Adalet Demir, MD, Akif Turna, MD, PhD, FETCS,

Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer Raymond U.

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

The Prognostic Value of the Number of Negative Lymph Nodes in Esophageal Cancer Patients After Transthoracic Resection Po-Kuei Hsu, MD, Chien-Sheng Huang,

Intrathoracic Lymph Node Metastases From Extrathoracic Carcinoma: The Place for Surgery Marc Riquet, MD, Pascal Berna, MD, Emmanuel Brian, MD, Alain.

Extent of Lymphadenectomy Is Associated With Improved Overall Survival After Esophagectomy With or Without Induction Therapy Pamela Samson, MD, MPHS,

Embolized Methyl Methacrylate to the Right Atrium After Kyphoplasty

Lymph Node Assessment and Impact on Survival in Video-Assisted Thoracoscopic Lobectomy or Segmentectomy Haiyu Zhou, MD, Luis F. Tapias, MD, Henning A.

William M. Whited, MD, Paul Henley, BS, Erin M

P The Reach and Adoption of a Multidisciplinary Thoracic Oncology Program within a U.S. Community Healthcare System Fedoria Rugless, Matthew.

Asvin M. Ganapathi, MD, Paul J. Speicher, MD, Anthony W

Endobronchial and Endoscopic Ultrasound-Guided Transvascular Biopsy of Mediastinal, Hilar, and Lung Lesions Jordan Kazakov, MD, Pravachan Hegde, MD,

Specialty Training and Mortality After Esophageal Cancer Resection

Prognosis of Patients With Pathologic T0 N+ Esophageal Squamous Cell Carcinoma After Chemoradiotherapy and Surgical Resection: Results From a Nationwide.

Use of a Surgical Specimen-Collection Kit to Improve Mediastinal Lymph-Node Examination of Resectable Lung Cancer Raymond U. Osarogiagbon, MBBS, FACP,

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

“Prophylactic” Tricuspid Repair for Functional Tricuspid Regurgitation

Digital Drainage System Reduces Hospitalization After Video-Assisted Thoracoscopic Surgery Lung Resection Daniel L. Miller, MD, Gerald A. Helms, MD,

Matthew J. Schuchert, MD, Omar Awais, DO, Ghulam Abbas, MD, Zachary D

The American Board of Thoracic Surgery: Update

Mert Saynak, MD, Jessica Hubbs, MS, Jiho Nam, MD, Lawrence B

“Transitions” for Cardiothoracic Surgeons Now Listed on the Web:

Mediastinal Paragangliomas: The Mayo Clinic Experience

Lung Retransplantation for Chronic Rejection: A Single-Center Experience Sreeja Biswas Roy, MBBS, Roshan Panchanathan, BS, Rajat Walia, MD, Katherine.

Mark I. Block, MD The Annals of Thoracic Surgery

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

The Impact of New Technology on Cardiothoracic Surgical Practice

Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation Marat Fudim, MD, Mary E. Davis, MS,

Presentation transcript:

Prognostic Value of National Comprehensive Cancer Network Lung Cancer Resection Quality Criteria Raymond U. Osarogiagbon, MBBS, Meredith A. Ray, MPH, PhD, Nicholas R. Faris, MDiv, Matthew P. Smeltzer, MStat, PhD, Carrie Fehnel, BBA, Cheryl Houston-Harris, BS, CCRP, Raymond S. Signore, RNFA, Laura M. McHugh, RN, Paul Levy, MD, Lynn Wiggins, MD, Vishal Sachdev, MD, Edward T. Robbins, MD The Annals of Thoracic Surgery Volume 103, Issue 5, Pages 1557-1565 (May 2017) DOI: 10.1016/j.athoracsur.2017.01.098 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 National Comprehensive Cancer Network (NCCN) lung cancer resection quality criteria attainment by year: (A) anatomic resection; (B) negative margins; (C) hilar lymph node examination; (D) examination of three or more mediastinal lymph node stations; (E) all four criteria. The Annals of Thoracic Surgery 2017 103, 1557-1565DOI: (10.1016/j.athoracsur.2017.01.098) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Survival impact of attaining National Comprehensive Cancer Network resection quality criteria: (A) anatomic resection (anatomic, blue; no anatomic resection, red); (B) negative margins (negative margin no, blue; negative margin yes, red); (C) hilar node examination (hilar station sampled no, blue; hilar station sampled yes, red); (D) three or more mediastinal stations (mediastinal node station no, blue; mediastinal node station yes, red). The Annals of Thoracic Surgery 2017 103, 1557-1565DOI: (10.1016/j.athoracsur.2017.01.098) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Survival impact of attaining National Comprehensive Cancer Network lung cancer resection quality criteria stratified by (A) number of criteria met (0 met, blue; 1 met, red; 2 met, green; 3 met, brown; 4 met, purple); and (B) whether all four criteria were met (all met no, blue; all met yes, red). The Annals of Thoracic Surgery 2017 103, 1557-1565DOI: (10.1016/j.athoracsur.2017.01.098) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions